Laura Llewellyn

Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment of patients with primary sclerosing cholangitis (BUTEO): A single-arm, two-stage, open-label, multi-centre, phase II clinical trial protocol

C. Weston, D. Adams, G. Hirschfield, 2017, BMJ Open.

Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocol

K. Harrington, C. Yap, Joanna L. Parish, 2020, BMJ Open.